Get the Stockscreener App
6.05
0.67%
0.04
After Hours:
6.09
0.04
+0.66%
Nutriband Inc stock is traded at $6.05, with a volume of 20,877.
It is up +0.67% in the last 24 hours and up +48.28% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$6.01
Open:
$5.9
24h Volume:
20,877
Relative Volume:
0.56
Market Cap:
$67.13M
Revenue:
$2.09M
Net Income/Loss:
$-5.28M
P/E Ratio:
-10.25
EPS:
-0.59
Net Cash Flow:
$-3.64M
1W Performance:
-9.97%
1M Performance:
+48.28%
6M Performance:
+33.85%
1Y Performance:
+137.25%
1-Day Range:
$5.843
$6.116
1-Week Range:
$5.82
$7.0861
52-Week Range:
$1.53
$9.595
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Nutriband Inc Stock (NTRB) Latest News
(NTRB) Trading Signals - Stock Traders Daily
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology - MSN
Head to Head Review: Nutriband (NASDAQ:NTRB) and Jin Medical International (NASDAQ:ZJYL) - Defense World
Nutriband secures patent in China for abuse-deterrent patch - Investing.com
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology - AccessWire
Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology - StockTitan
Nutriband Inc (NTRB-Q) QuotePress Release - The Globe and Mail
The 5 Public Companies Leading the Fight Against Fentanyl — Plus 10 Facts You Should Know - InvestorNews Inc.
Nutriband inks deal to enhance opioid patch safety - Investing.com
Nutriband inks deal to enhance opioid patch safety By Investing.com - Investing.com Canada
Nutriband inks deal to enhance opioid patch safety - Investing.com India
Nutriband inks deal to enhance opioid patch safety By Investing.com - Investing.com UK
Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead ProductAversa(TM) Fentanyl Transdermal Patch - AccessWire
Bubble Tea Craze Hits Par Market with New Ninja Bubble Tea Shop - Cornish Stuff
Keith Martell Purchases 1,250 Shares of Nutrien Ltd. (TSE:NTR) Stock - MarketBeat
Nutrien Ltd (NTR) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
NutriLab Joins NeoSpectra LabStore, Expanding Options for Quick On-Site Analysis of Feed and Feed Ingredients - AccessWire
Massachusetts Financial Services Co. MA Has $133.43 Million Stock Position in Nutrien Ltd. (NYSE:NTR) - MarketBeat
PATS previews: Key focus for Nutriment - Pet Business World News
Insider Buying: Nutrien Ltd. (TSE:NTR) Senior Officer Buys 300 Shares of Stock - Defense World
Nutriband Announces Stock Buyback and Advances in Fentanyl Patch Development - TipRanks
NTR’s Q2 earnings predictions: What the experts say - US Post News
Daiwa Securities Group Inc. Purchases Shares of 1,832 Nutrien Ltd. (NYSE:NTR) - Defense World
Nutrien wins NSC Safety Innovation Award and celebrates two semi-finalist achievements - Nutrien
Marriage’s launches new Nutri Pressed range - Pet Gazette
Houweling Americas announces exclusive partnership with Nutrien Solutions in British Columbia - hortidaily.com
No Frills Grocery to take over former Nesters Market at Gordon and Bernard - Castanet.net
Is ProstaLite the Natural Solution for Prostate Support? A Comprehensive Review - Islands' Sounder
How To Balance A Tech Job & Cricket? Learn The Saurabh Netravalkar Way- WATCH - Times Now
Nutriband to repurchase $1 million in common stock - Investing.com India
Shoppers can’t get over with this NutriBullet kitchen essential on sale for under $100 - LADbible
Nutriband to repurchase $1 million in common stock By Investing.com - Investing.com Canada
Nutricare launches first aid products for pets - Inside FMCG
Nutriband to repurchase $1 million in common stock - Investing.com
Nutrien Ltd. stock falls Monday, underperforms market - MarketWatch
Nutriband to repurchase $1 million in common stock By Investing.com - Investing.com UK
Nutriband Inc. Authorizes $1M Share Buyback Program - AccessWire
Nutrien: Short-Termism Creates Opportunities For Long-Term Investors (Rating Upgrade) - Seeking Alpha
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update - MSN
Nutriband (NASDAQ:NTRBW) Shares Up 2.1% - Defense World
Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail
Nutriband Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2024 - Marketscreener.com
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - StockTitan
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 - AccessWire
(NTRB) Proactive Strategies - Stock Traders Daily
Financial Review: Nutriband (NASDAQ:NTRB) and ReWalk Robotics (NASDAQ:LFWD) - Defense World
Nutriband (NASDAQ:NTRBW) Stock Price Down 40.3% - Defense World
Virtu Financial LLC Takes $58,000 Position in Nutriband Inc. (NASDAQ:NTRB) - Defense World
Long Term Trading Analysis for (NTRB) - Stock Traders Daily
Nutriband (NASDAQ: NTRB) Names Seasoned Business Leader To Board Of Directors - Barchart
Nutriband (NASDAQ: NTRB) Execs To Participate In July 25 Investor Webinar - Barchart
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):